Neuphoria Therapeutics Inc.

Develops novel ion channel modulators for treating neuropsychiatric disorders like anxiety & PTSD.

NEUP | NDAQ

Overview

Corporate Details

ISIN(s):: US64136E1029 (+1 more)
LEI:
Country:: United States of America
Address:: 100 SUMMIT DR, 1803 BURLINGTON
Website:: https://www.neuphoriatx.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Neuphoria Therapeutics Inc. is a clinical-stage biopharmaceutical company that discovers and develops novel allosteric ion channel modulators for the treatment of neuropsychiatric disorders. The company's mission is to address the unmet needs of individuals affected by complex conditions such as anxiety and Post-Traumatic Stress Disorder (PTSD). Its lead drug candidate, BNC210, is a first-in-class anti-anxiety medication designed to offer rapid relief without the common side effects of traditional treatments, such as sedation, cognitive impairment, or addiction potential. The therapy utilizes a novel mechanism of action to restore balance in brain chemistry, offering a potential alternative to current treatments.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Neuphoria Therapeutics Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Neuphoria Therapeutics Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Neuphoria Therapeutics Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
ALK-Abelló Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.	Denmark	ALK
Alkaloid AD Manufactures pharmaceuticals, cosmetics, and herbal products for professionals and consumers.	North Macedonia	ALK
Alkermes plc. Develops medicines for CNS disorders like schizophrenia, bipolar, and sleep disorders.	United States of America	ALKS
Allarity Therapeutics, Inc. Develops personalized cancer drugs using a diagnostic platform to predict patient response.	United States of America	ALLR
ALLERGY THERAPEUTICS PLC Develops innovative, aluminum-free allergy immunotherapy vaccines for the European market.	United Kingdom	AGY
Alligator Bioscience Develops immuno-oncology antibody drugs to activate the immune system against hard-to-treat cancers.	Sweden	ATORX
Allogene Therapeutics, Inc. Developing off-the-shelf CAR T-cell therapies for cancer and autoimmune diseases.	United States of America	ALLO
Alma Yesodot Ltd.	Israel	KVSR
Almirall S.A. A global biopharmaceutical company developing innovative medical solutions for skin health.	Spain	ALM
ALNYLAM PHARMACEUTICALS, INC. Pioneering RNAi gene-silencing therapies for rare genetic and cardiometabolic diseases.	United States of America	ALNY